Edition:
United States

Precision Therapeutics Inc (AIPT.OQ)

AIPT.OQ on NASDAQ Stock Exchange Capital Market

1.17USD
20 Aug 2018
Change (% chg)

-- (--)
Prev Close
$1.17
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
39,705
52-wk High
$2.50
52-wk Low
$0.81

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.41 -0.155
FY 2017 Dec '17 0.22 -0.435
Sep '17 0.15 -0.159
Jun '17 0.11 -0.412
Mar '17 0.18 -0.208
FY 2016 Dec '16 0.14 -0.161
Sep '16 0.13 -0.318
Jun '16 0.09 -0.950
Mar '16 0.10 -3.007
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

No consensus analysis data available.

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 44.74 30.45
P/E High - Last 5 Yrs. -- 79.14 47.36
P/E Low - Last 5 Yrs. -- 22.88 24.74
Beta 1.06 0.86 0.84
Price to Sales (TTM) 15.63 23.68 5.98
Price to Book (MRQ) 2.64 5.24 3.69
Price to Tangible Book (MRQ) 2.73 11.24 5.63
Price to Cash Flow (TTM) -- 25.50 20.97
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.65 1.78
Dividend Yield - 5 Year Avg -- 0.68 1.46
Dividend 5 Year Growth Rate -- 5.18 -5.93
Payout Ratio(TTM) -- 23.64 46.55

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 134.97 8.41 7.18
Sales (TTM) vs TTM 1 Yr. Ago 66.67 9.32 12.05
Sales - 5 Yr. Growth Rate 28.25 5.27 7.61
EPS (MRQ) vs Qtr. 1 Yr. Ago 25.67 473.42 23.85
EPS (TTM) vs TTM 1 Yr. Ago 29.09 -- --
EPS - 5 Yr. Growth Rate -- 18.06 7.52
Capital Spending - 5 Yr. Growth Rate -- 11.20 8.06

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 3.64 1.72 2.50
Current Ratio (MRQ) 3.99 2.23 3.53
LT Debt to Equity (MRQ) 0.00 31.39 11.27
Total Debt to Equity (MRQ) 0.00 43.09 14.23
Interest Coverage (TTM) -- 11.80 31.77

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 74.37 46.26 55.23
Gross Margin - 5 Yr. Avg. 62.06 55.94 53.33
EBITD Margin (TTM) -908.11 -- --
EBITD - 5 Yr. Avg -1,055.53 12.99 15.82
Operating Margin (TTM) -916.09 -18.24 3.86
Operating Margin - 5 Yr. Avg. -1,108.28 4.82 10.95
Pre-Tax Margin (TTM) -916.09 -18.70 4.16
Pre-Tax Margin - 5 Yr. Avg. -1,108.28 3.00 11.12
Net Profit Margin (TTM) -916.09 -21.10 0.98
Net Profit Margin - 5 Yr. Avg. -1,108.28 0.80 7.47
Effective Tax Rate (TTM) -- 24.84 20.36
Effective Tax Rate - 5 Yr. Avg. -- 21.86 24.15

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 13,785,727 718,909,906
Net Income/Employee (TTM) -- 672,401 83,624,743
Receivable Turnover (TTM) 5.75 5.20 5.38
Inventory Turnover (TTM) 0.88 4.82 3.51
Asset Turnover (TTM) 0.16 0.76 0.83

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -142.42 2.21 10.04
Return on Assets - 5 Yr. Avg. -295.89 5.47 10.94
Return on Investment (TTM) -173.99 7.91 12.63
Return on Investment - 5 Yr. Avg. -- 6.81 14.14
Return on Equity (TTM) -177.55 11.65 14.82
Return on Equity - 5 Yr. Avg. -- 8.12 15.50
  1 Year 3 Year 5 Year
Sales % 43.45 -11.71 28.25
EPS (TTM) % 47.33 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Precision Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 6.41%
# of Holders: 15
Total Shares Held: 858,497
3 Mo. Net Change: -19,938
# New Positions: 2
# Closed Positions: 3
# Increased Positions: 3
# Reduced Positions: 4
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.